About ExRNA
Manuscript Submission
AME Editing Service
Reprint & Permission
Advertising
Contact us
-
General editorial enquiries:
Email: exrna@amepc.org -
Copyright related contact:
Email: permissions@amegroups.com -
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com
Original Article
ExRNA
2023;
5:
4
(27 September 2023)
Review Article
ExRNA
2023;
5:
3
(22 September 2023)
Review Article
ExRNA
2023;
5:
2
(31 July 2023)
Review Article
ExRNA
2023;
5:
1
(30 January 2023)
Letter to the Editor
ExRNA
2022;
4:
27
(30 December 2022)
Review Article
ExRNA
2022;
4:
26
(30 December 2022)
Editorial Commentary
ExRNA
2022;
4:
25
(30 November 2022)
Review Article
ExRNA
2022;
4:
24
(30 November 2022)
Editorial Commentary
ExRNA
2022;
4:
23
(31 October 2022)
Review Article
ExRNA
2022;
4:
22
(31 October 2022)
Editorial Commentary
ExRNA
2022;
4:
21
(30 September 2022)
Original Article
ExRNA
2022;
4:
20
(30 September 2022)
Letter to the Editor
ExRNA
2022;
4:
19
(30 August 2022)
Review Article
ExRNA
2022;
4:
18
(30 August 2022)
Editorial Commentary
ExRNA
2022;
4:
17
(30 July 2022)
Letter to the Editor
ExRNA
2022;
4:
15
(30 June 2022)
Review Article
ExRNA
2022;
4:
14
(30 June 2022)
Editorial Commentary
ExRNA
2022;
4:
13
(31 May 2022)
Review Article
ExRNA
2022;
4:
12
(31 May 2022)
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Editorial Commentary
Original Article
Review Article
Review Article
Review Article
Original Article
Editorial Commentary
Editorial Commentary
Letter to the Editor
Original Article
Editorial Commentary
Editorial Commentary
Editorial Commentary
Currently no content available!